✦ LIBER ✦

COMPARISON OF DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND VALVULAR HEART DISEASE: THE RE-LY® TRIAL

✍ Scribed by Ezekowitz, Michael D.; Parise, Helen; Nagarakanti, Rangadham; Noack, Herbert; Brueckmann, Martina; Clemens, Andreas; Reilly, Paul; Connolly, Stuart; Yusuf, Salim; Wallentin, Lars

Book ID: 123494351
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 235 KB
Volume: 63
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(14)60325-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DABIGATRAN ETEXILATE VERSUS WARFARIN IN

DABIGATRAN ETEXILATE VERSUS WARFARIN IN PATIENTS WITH DIFFERENT TYPES OF ATRIAL FIBRILLATION: A RE-LY® SUBGROUP ANALYSIS

✍ Greg C. Flaker; Paul Reilly; Salim Yusuf; Mike Ezekowitz; Lars Wallentin; Martin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 193 KB

DABIGATRAN VERSUS WARFARIN IN ATRIAL FIB

DABIGATRAN VERSUS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH LOW, MODERATE AND HIGH CHADS2 SCORE: A RE-LY SUBGROUP ANALYSIS

✍ Jonas Oldgren; Marco Alings; Harald Darius; John Eikelboom; Michael Ezekowitz; A 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Population pharmacokinetic analysis of t

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial

✍ K.-H. LIESENFELD; T. LEHR; C. DANSIRIKUL; P. A. REILLY; S. J. CONNOLLY; M. D. EZ 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

DABIGATRAN VERSUS WARFARIN AND IMPACT OF

DABIGATRAN VERSUS WARFARIN AND IMPACT OF CHAD2-VASC SCORE ON OUTCOME IN ATRIAL FIBRILLATION PATIENTS: A RE-LY SUBGROUP ANALYSIS

✍ Jonas Oldgren; Michael D. Ezekowitz; Marco Alings; Hans-Christoph Diener; Paul A 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Dabigatran compared with warfarin in pat

Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial

✍ Hans-Christoph Diener; Stuart J Connolly; Michael D Ezekowitz; Lars Wallentin; P 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 177 KB

Population pharmacokinetic analysis of t

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial: a rebuttal

✍ J. P. PATEL; B. GREEN; R. K. PATEL; J. G. DAVIES; R. ARYA 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB